Greta Garrido

Greta Garrido, PhD, currently serves as the TCR & Epitope Discovery Director at Gritstone bio, a position held since January 2023. Prior to this role, Greta contributed to Nurix Therapeutics as Associate Director, leading innovative research in drug-enhanced Tumor Infiltrating Lymphocytes (DeTIL) programs and potency assay development. Additional experience includes serving as Principal Scientist in cell therapy at Nurix and as Senior Scientist at BlueSphere Bio, where Greta focused on personalized TCR discovery and neoantigen strategies. Earlier roles involved research at the University of Miami, the Center of Molecular Immunology, and extensive work during graduate studies at the University of Havana, culminating in a PhD in Biological Sciences with a specialization in cancer immunotherapy and immunology.